TCL Archive PR firm Edelman worked for a tobacco company and the National Dialogue on Cancer, despite a promise to the Dialogue that Edelman companies would no longer serve tobacco clients. July 25, 2003
TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says November 28, 2014
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants April 8, 1977
